SCHEMBL5070013

SCHEMBL5070013

CCCCCCCCCCCCCCCC(=O)OC(=N)CCC(=O)OC(=O)CCCCCCCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.52
LMNA P02545 2/20 0.48
PAM P19021 2/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
MAPK1 P28482 1/20 0.46
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
TSHR P16473 4/20 0.44
HSP90AA1 P07900 1/20 0.44
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10949517 1.00 DGKA (0.52) DGKALMNAPAMALDH1A1MAPT
SCHEMBL1361855 1.00 DGKA (0.52) DGKALMNAPAMALDH1A1MAPT
SCHEMBL6889455 1.00 DGKA (0.52) DGKALMNAPAMALDH1A1MAPT
SCHEMBL11639759 1.00 DGKA (0.52) DGKALMNAPAMALDH1A1MAPT
SCHEMBL9565427 1.00 DGKA (0.52) DGKALMNAPAMALDH1A1MAPT
SCHEMBL6535867 0.98 DGKA (0.48) DGKALMNAPAMALDH1A1MAPT
SCHEMBL6526444 0.92 ALDH1A1 (0.50) DGKALMNAPAMALDH1A1MAPT
SCHEMBL28181086 0.90 DGKA (0.53) DGKALMNAPAMALDH1A1MAPT
SCHEMBL2779344 0.90 CNR2 (0.55) DGKALMNAMAPTPPARGPPARD
SCHEMBL28199038 0.88 DGKA (0.50) DGKALMNAPAMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113967267-B Endoplasmic reticulum targeting of fatty acid modified albumin and uses thereof 四川大学 2022-10-25 CN disclosed
CN-113967267-A Endoplasmic reticulum targeting of fatty acid modified albumin and uses thereof 四川大学 2022-01-25 CN disclosed
CN-112999356-A Scavenger receptor-A targeted fatty acid modified albumin nanoparticle and preparation method and application thereof 四川大学 2021-06-22 CN disclosed
CN-111909073-A Method for preparing high-purity fatty acid derivative 江苏万邦医药科技有限公司 2020-11-10 CN disclosed
WO-2012166810-A1 BIOLOGICALLY ACTIVE TRI-PEPTIDE AMPLIFI BIOTECHNOLOGIES, INC. (US) 2012-12-06 WO disclosed
EP-1613343-A4 INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME BIOCON LTD (IN) 2008-03-05 EP disclosed
EP-1613343-A2 INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME Nobex Corporation (US) 2006-01-11 EP disclosed
EP-1430082-A4 METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME NOBEX CORP (US) 2004-11-24 EP disclosed
WO-2004083234-A2 INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME NOBEX CORPORATION (US) 2004-09-30 WO disclosed
EP-1430082-A2 METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME Nobex Corporation (US) 2004-06-23 EP disclosed
WO-2003022996-A2 METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME NOBEX CORPORATION (US) 2003-03-20 WO disclosed
WO-1996015803-A1 SELECTIVE ACYLATION OF ε-AMINO GROUPS ELI LILLY AND COMPANY (US) 1996-05-30 WO disclosed
US-4126628-A BASIC CATALYST CANADIAN PATENTS AND DEVELOPMENT LIMITED (CA) 1978-11-21 US disclosed